Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
View ORCID ProfileCM Nielsen, JR Barrett, C Davis, JK Fallon, C Goh, AR Michell, C Griffin, View ORCID ProfileA Kwok, View ORCID ProfileC Loos, S Darko, F Laboune, SE Silk, View ORCID ProfileM Tekman, JR Francica, A Ransier, RO Payne, View ORCID ProfileAM Minassian, DA Lauffenburger, RA Seder, DC Douek, View ORCID ProfileG Alter, View ORCID ProfileSJ Draper
doi: https://doi.org/10.1101/2022.04.25.22274161
CM Nielsen
1University of Oxford, Oxford, United Kingdom
JR Barrett
1University of Oxford, Oxford, United Kingdom
C Davis
2Department of Biological Engineering, MIT, Cambridge, USA
JK Fallon
3Ragon Institute of MGH, MIT and Harvard, Boston, USA
C Goh
1University of Oxford, Oxford, United Kingdom
AR Michell
3Ragon Institute of MGH, MIT and Harvard, Boston, USA
C Griffin
2Department of Biological Engineering, MIT, Cambridge, USA
A Kwok
1University of Oxford, Oxford, United Kingdom
5Wellcome Center for Human Genetics, University of Oxford, Oxford, United Kingdom
C Loos
2Department of Biological Engineering, MIT, Cambridge, USA
3Ragon Institute of MGH, MIT and Harvard, Boston, USA
S Darko
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
F Laboune
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
SE Silk
1University of Oxford, Oxford, United Kingdom
M Tekman
7Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
JR Francica
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
A Ransier
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
RO Payne
1University of Oxford, Oxford, United Kingdom
AM Minassian
1University of Oxford, Oxford, United Kingdom
DA Lauffenburger
2Department of Biological Engineering, MIT, Cambridge, USA
RA Seder
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
DC Douek
6Vaccine Research Center, NIAID/NIH, Bethesda, USA
G Alter
3Ragon Institute of MGH, MIT and Harvard, Boston, USA
SJ Draper
1University of Oxford, Oxford, United Kingdom

Article usage
Posted April 27, 2022.
Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
CM Nielsen, JR Barrett, C Davis, JK Fallon, C Goh, AR Michell, C Griffin, A Kwok, C Loos, S Darko, F Laboune, SE Silk, M Tekman, JR Francica, A Ransier, RO Payne, AM Minassian, DA Lauffenburger, RA Seder, DC Douek, G Alter, SJ Draper
medRxiv 2022.04.25.22274161; doi: https://doi.org/10.1101/2022.04.25.22274161
Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
CM Nielsen, JR Barrett, C Davis, JK Fallon, C Goh, AR Michell, C Griffin, A Kwok, C Loos, S Darko, F Laboune, SE Silk, M Tekman, JR Francica, A Ransier, RO Payne, AM Minassian, DA Lauffenburger, RA Seder, DC Douek, G Alter, SJ Draper
medRxiv 2022.04.25.22274161; doi: https://doi.org/10.1101/2022.04.25.22274161
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)